Accreditation Statement and Credit Designation
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
How to Receive Credit
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 2.0 AMA PRA Category 1 Credits™. You must complete the post-test and evaluation in order to receive credit for this activity.
All other participants who successfully complete the post-test and evaluation will receive a certificate of completion.
A statement of credit will be e-mailed to you and will also be available to print from your user history page.
Disclosure of Conflicts of Interest
In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
William J. Sandborn, MD, has affiliations with Janssen, Abbott Laboratories (now Abbvie), UCB Pharma, Salix, Shire, Warner Chilcott, Prometheus Laboratories, Santarus, Bristol-Myers Squibb, Genentech, Amgen, Pfizer, Receptos, GlaxoSmithKline and Millennium (a Takeda company) (Consulting); Abbvie (Speakers Bureau); and Janssen, Bristol-Myers Squibb, Genentech, Amgen, Pfizer, Receptos and GlaxoSmithKline (Research).
Marla C. Dubinsky, MD, has affiliations with Janssen, Pfizer, Bristol-Myers Squibb, UCB, Abbott, Shire, Prometheus and Takeda (Consulting); and Janssen (Research).
Brian G. Feagan, MD, has affiliations with Abbott, ActoGeniX, Bristol-Myers Squibb, Centocor, CombinatoRx, Elan/Biogen, Genentech, Merck, Millennium, Novartis, Protein Design Labs, Tillotts, UCB Pharma and Wyeth (Grant/Research); Abbott (AbbVie), ActoGeniX, Albireo Pharma, Amgen, AstraZeneca, Athersys, Avaxia Biologics Inc., Axcan, Boehringer-Ingelheim France, Bristol-Myers Squibb, Celgene, Centocor, Elan/Biogen, Ferring Pharma A/S, Genentech, GiCare Pharma, Gilead, Given Imaging Inc., GSK, Ironwood Pharma, J&J/Janssen, Merck, Millennium, Nektar, Novo Nordisk, Prometheus Therapeutics and Diagnostics, Pfizer, Salix Pharma, Serono, Shire, Sigmoid Pharma, Synergy Pharma Inc., Takeda, Teva Pharma, Tillotts, UCB Pharma, Unity Pharmaceuticals, Warner-Chilcott, Wyeth, Zealand Pharm and Zyngenia (Consulting); Abbott, J&J/Janssen and UCB Pharma (Speakers Bureau); and Abbott, AstraZeneca, Celgene, Centocor Inc., Elan/Biogen, Merck, Novartis, Pfizer, Prometheus Laboratories, Salix Pharma, Takeda, Tillotts Pharma AG and UCB Pharma (Advisory Board).
Program planners reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
Cynthia M. Kunzer has no affiliations with commercial interests to disclose.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information and comparison with recommendations of other authorities.
This is a program of the AGA Institute in collaboration with RMEI, LLC. RMEI gratefully acknowledges an educational grant from Takeda Pharmaceuticals International, Inc., US Region in support of this CME activity.
There is no fee for this educational activity.